<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url>
    <loc>https://pharmadog.xyz/news/499607</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-05T12:19:11.000Z</news:publication_date>
      <news:title>STAT+: Vaxcyte claims success in bid to beat Pfizer and Merck in lucrative vaccine market</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/499608</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-05T12:00:51.000Z</news:publication_date>
      <news:title>Could we one day vaccinate against every cancer?</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/499395</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-05T11:08:36.000Z</news:publication_date>
      <news:title>Nobel prize honors scientists who pioneered light-activated gene therapy technology</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/499396</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-05T11:00:27.000Z</news:publication_date>
      <news:title>Sensible Bio raises $47 million Series A to build mRNA therapy manufacturing platform</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/499397</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-05T11:00:22.000Z</news:publication_date>
      <news:title>Epicrispr reports encouraging early data from EPI-321 in 12 patients with FSHD</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/499103</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-05T10:00:11.000Z</news:publication_date>
      <news:title>2026 Nobel Prize in Medicine awarded for optogenetics, the light-controlled brain research tool</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/499015</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-05T09:00:00.000Z</news:publication_date>
      <news:title>Diagnostic-driven therapies face patient loss due to workflow gaps, new commercialization model proposed</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/499016</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-05T09:00:00.000Z</news:publication_date>
      <news:title>AI drives faster drug development and reshapes biopharma manufacturing facilities</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/498829</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-05T08:30:00.000Z</news:publication_date>
      <news:title>Late-stage mRNA melanoma vaccine shows promise, slowing disease recurrence</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/498830</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-05T08:30:00.000Z</news:publication_date>
      <news:title>Rising Hospital and Drug Prices Drive Up Insurance Premiums for Workers and Employers</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/498831</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-05T08:30:00.000Z</news:publication_date>
      <news:title>Energy drinks partner with college sports, raising safety concerns for teens</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/498828</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-05T08:30:00.000Z</news:publication_date>
      <news:title>Will AI like Claude ever earn a Nobel Prize in medicine?</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/498827</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-05T08:30:00.000Z</news:publication_date>
      <news:title>Stem cell advocates anticipate FDA roundtables as peptide therapies gain regulatory foothold</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/499538</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-05T08:16:00.000Z</news:publication_date>
      <news:title>Vaxcyte’s stock jumps as pneumococcal vaccine holds its own against Pfizer&apos;s, Merck’s shots</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/499371</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-05T06:40:00.000Z</news:publication_date>
      <news:title>Scientists awarded 2026 Nobel Prize for pioneering optogenetics light-switch technique</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/498135</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-05T04:44:00.000Z</news:publication_date>
      <news:title>Kyverna Therapeutics reports encouraging data for first CAR-T therapy targeting autoimmune disease</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/499036</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-05T04:16:00.000Z</news:publication_date>
      <news:title>CSL pays $355M upfront to co-develop Alentis’ phase-2 fibrosis drug lixudebart</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/498759</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-05T04:15:00.000Z</news:publication_date>
      <news:title>Genmab’s Rina-S ADC shows 9.5-month median PFS, touted as superior to AbbVie’s Elahere</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/498136</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-05T04:03:00.000Z</news:publication_date>
      <news:title>Roivant Sciences launches first solo drug, Lisraya, after FDA approval for dermatomyositis</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/498137</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-05T04:02:00.000Z</news:publication_date>
      <news:title>FDA urged to boost US access to new and experimental drugs as trials shift to China</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/498138</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-05T04:01:00.000Z</news:publication_date>
      <news:title>Swiss CDMOs and CROs experience rapid growth as global sponsors seek specialized manufacturing and decentralized trials</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/497775</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-05T02:22:24.000Z</news:publication_date>
      <news:title>CSL agrees $355M upfront deal to co-develop Alentis anti-fibrosis drug for kidney and liver</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/495707</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-04T16:58:12.000Z</news:publication_date>
      <news:title>Trump pledges $90 one-time Medicare Part B premium payment to over 20 million seniors before midterms</news:title>
    </news:news>
  </url>
</urlset>
